SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 240 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,564 | +141.0% | 56,739 | +162.8% | 0.02% | +166.7% |
| Q2 2023 | $649 | -63.8% | 21,594 | -56.3% | 0.01% | -72.7% |
| Q1 2023 | $1,792 | +60.7% | 49,464 | +58.1% | 0.02% | +37.5% |
| Q4 2022 | $1,115 | -99.9% | 31,281 | -40.5% | 0.02% | -15.8% |
| Q3 2022 | $1,780,000 | +420.5% | 52,598 | +344.2% | 0.02% | +375.0% |
| Q2 2022 | $342,000 | -85.4% | 11,841 | -85.3% | 0.00% | -71.4% |
| Q4 2021 | $2,349,000 | +312.1% | 80,576 | +277.0% | 0.01% | +366.7% |
| Q3 2021 | $570,000 | +68.1% | 21,374 | +49.7% | 0.00% | -70.0% |
| Q2 2020 | $339,000 | – | 14,282 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |